The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical characteristics of NSCLC harboring ALK 2p23 translocation at Cleveland Clinic.
Yan Feng
No relevant relationships to disclose
Nathan A. Pennell
Consultant or Advisory Role - Boehringer Ingelheim; Oncogenex
Research Funding - Genentech
Julia Samsa
No relevant relationships to disclose
Christopher Lanigan
No relevant relationships to disclose
A. Valeria Arrossi
No relevant relationships to disclose
Carol Farver
No relevant relationships to disclose
Raymond R. Tubbs
No relevant relationships to disclose
Patrick C. Ma
No relevant relationships to disclose